What is Cardinal Health Inc. (CAH) Stock Return on Shareholders’ Capital?

Cardinal Health Inc. (NYSE: CAH) stock fell -0.37% on Friday to $67.27 against a previous-day closing price of $67.52. With 1.98 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.75 million shares. During the session, the Medical Distribution company that operates in wider Healthcare sector, reached to the highest price of $67.78 whereas the lowest price it dropped to was $66.71. The 52-week range on CAH shows that it touched its highest point at $72.28 and its lowest point at $45.85 during that stretch. It currently has a 1-year price target of $69.54. With its current market cap of 18.20 billion, CAH has annualized dividend of $1.98 while the current yield stands at 2.95%. Beta for the stock currently stands at 0.79.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CAH was up-trending over the past week, with a rise of 1.33%, but this was down by -1.04% over a month. Three-month performance surged to 26.88% while six-month performance rose 18.52%. The stock gained 31.88% in the past year, while it has gained 30.65% so far this year. A look at the trailing 12-month EPS for CAH yields -3.44 with Next year EPS estimates of 6.18. For the next quarter, that number is 1.03. This implies an EPS growth rate of -260.90% for this year and 16.99% for next year. EPS is expected to grow by 5.16% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -23.10%.

Float and Shares Shorts:

At present, 273.00 million CAH shares are outstanding with a float of 271.20 million shares on hand for trading. On Jul 14, 2022, short shares totaled 6.54 million, which was 2.40% higher than short shares on Jun 14, 2022. In addition to Mr. Michael C. Kaufmann as the firm’s CEO & Director, Mr. Jason M. Hollar serves as its Chief Financial Officer.

Institutional Ownership:

Through their ownership of 89.57% of CAH’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 52.78% of CAH, in contrast to 36.08% held by mutual funds. Shares owned by individuals account for 3.22%. As the largest shareholder in CAH with 11.91% of the stake, The Vanguard Group, Inc. holds 32,464,095 shares worth 32,464,095. A second-largest stockholder of CAH, SSgA Funds Management, Inc., holds 20,370,803 shares, controlling over 7.48% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in CAH, holding 13,742,594 shares or 5.04% stake. With a 2.96% stake in CAH, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 8,056,307 shares are owned by the mutual fund manager. The Vanguard Mid Cap Index Fund, which owns about 2.30% of CAH stock, is the second-largest Mutual Fund holder. It holds 6,254,380 shares valued at 442.31 million. Vanguard 500 Index Fund holds 2.23% of the stake in CAH, owning 6,078,478 shares worth 429.87 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CAH since 15 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 10 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 1 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CAH analysts setting a high price target of $80.00 and a low target of $57.00, the average target price over the next 12 months is $70.67. Based on these targets, CAH could surge 18.92% to reach the target high and fall by -15.27% to reach the target low. Reaching the average price target will result in a growth of 5.05% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. CAH will report FY 2023 earnings on 08/10/2023. Analysts have provided yearly estimates in a range of $5.33 being high and $5.17 being low. For CAH, this leads to a yearly average estimate of $5.25. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Cardinal Health Inc. surprised analysts by -$0.13 when it reported $1.05 EPS against a consensus estimate of $1.18. The surprise factor in the prior quarter was -$0.07. Based on analyst estimates, the high estimate for the next quarter is $1.20 and the low estimate is $0.90. The average estimate for the next quarter is thus $1.02.

Summary of Insider Activity:

Insiders traded CAH stock several times over the past three months with 16 Buys and 12 Sells. In these transactions, 527,938 shares were bought while 290,339 shares were sold. The number of buy transactions has increased to 27 while that of sell transactions has risen to 19 over the past year. The total number of shares bought during that period was 602,215 while 314,938 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam